Pharmaceutical 2-imidazolines have been investigated as antihyperglycemic, anti-inflammatory, antihypertensive, antihypercholesterolemic, and antidepressant reagents. The imidazoline-containing drug clonidine is used alone or in combination with other medications to treat high blood pressure. It is also used in the treatment of dysmenorrhea, hypertensive crisis, Tourette's syndrome and attention deficit hyperactivity disorder (ADHD). File:Clonidine.png|Clonidine File:Example_of_imidazoline_as_catalyst.png|Biimidazoline ligands and a complex. File:Grubbs_catalyst_Gen2.svg|Second generation
Grubbs' catalyst File:Spongotine B.png|Spongotine B
As p53 activators Cis-imidazolines act as small-molecule antagonists of
MDM2. These compounds bind MDM2/X in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice. The most active compounds are
nutlin-3a and rg-7112, but some other analogs also activate p53.
Surfactants Surfactants based around 2-imidazoline, such as
sodium lauroamphoacetate, are used in personal care products where mildness and non-irritancy are particularly important (e.g. baby products, "no more tears" shampoos etc.).
As precursors of imidazoles Imidazoles can be prepared from dehydrogenation of imidazolines.
Homogeneous catalysis As a structural analogue of
2-oxazolines, 2-imidazolines have been developed as
ligands in coordination chemistry. The substitutions on the nitrogen atom in the imidazoline ring provide opportunities for fine-tuning the electronic and steric properties. Some of the complexes function as catalysts for
Suzuki–Miyaura couplings,
Mizoroki–Heck reactions,
Diels–Alder reactions, asymmetric
allylic substitution, [3,3]
sigmatropic rearrangement,
Henry reactions. == See also ==